This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Georgantas, R. W. Articles by Civin, C. I. Search for Related Content PubMed PubMed Citation Articles by Georgantas, R. W., III Articles by Civin, C. I.

Microarray and Serial Analysis of Gene Expression Analyses Identify Known and Novel Transcripts Overexpressed in Hematopoietic Stem Cells

¹ Department of Oncology and Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland; Departments of ² Pediatrics and ³ Molecular Biology and Genetics, Johns Hopkins University School of Medicine, Baltimore, Maryland; ⁴ Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; and ⁵ School of Medicine, Duke University, Durham, North Carolina

The human CD34⁺/CD38^–/Lin^– cell subset, comprising 1–10% of the CD34⁺ cell population, contains few of the less primitive hematopoietic (lineage-committed) progenitor cells (HPCs) but most of the primitive in vivo engrafting (lympho-)hematopoietic stem cells (HSCs). We analyzed gene expression in CD34⁺/CD38^–/Lin^– cell populations isolated from normal human adult donor bone marrow, neonatal placental/umbilical cord blood, and mobilized adult donor peripheral blood stem-progenitor cells. As measured by Affymetrix microarrays, 4746 genes were expressed in CD34⁺/CD38^–/Lin^– cells from all three tissues. We also determined the transcriptomes of the stem cell-depleted, HPC-enriched CD34⁺/[CD38/Lin]⁺⁺ cell population from each tissue. Comparison of CD34⁺/CD38^–/Lin^– (HSC-enriched) versus CD34⁺/[CD38/Lin]⁺⁺ (HPC-enriched, HSC-depleted) cells from each tissue yielded 81 genes overrepresented and 90 genes underrepresented, common to all three of the CD34⁺/CD38^–/Lin^– cell populations. These transcripts, which are selectively expressed in HSCs from all three tissues, include a number of known genes (e.g., transcription factors, receptors, and signaling molecules) that might play roles in key functions (e.g., survival, self-renewal, differentiation, and/or migration/adhesion) of human HSCs. Many genes/transcripts of unknown function were also detected by microarray analysis. Serial analysis of gene expression of the bone marrow HSC and HPC populations confirmed expression of most of the overrepresented transcripts for which reliable serial analysis of gene expression tags were detected and additionally suggested that current microarrays do not detect as many as 30% of the transcripts expressed in HSCs, including a number of previously unknown transcripts. This work is a step toward full definition of the transcriptome of normal human HSCs and may identify new genes involved in leukemogenesis and cancer stem cells.

This article has been cited by other articles:

				Y. C. Kim, Q. Wu, J. Chen, Z. Xuan, Y.-C. Jung, M. Q. Zhang, J. D. Rowley, and S. M. Wang The transcriptome of human CD34+ hematopoietic stem-progenitor cells PNAS, May 19, 2009; 106(20): 8278 - 8283. [Abstract] [Full Text] [PDF]

				C. G. Mullighan, X. Su, J. Zhang, I. Radtke, L. A.A. Phillips, C. B. Miller, J. Ma, W. Liu, C. Cheng, B. A. Schulman, et al. Deletion of IKZF1 and Prognosis in Acute Lymphoblastic Leukemia N. Engl. J. Med., January 29, 2009; 360(5): 470 - 480. [Abstract] [Full Text] [PDF]

				J. Maes, M. Maleszewska, C. Guillemin, F. Pflumio, E. Six, I. Andre-Schmutz, M. Cavazzana-Calvo, D. Charron, C. Francastel, and M. Goodhardt Lymphoid-affiliated genes are associated with active histone modifications in human hematopoietic stem cells Blood, October 1, 2008; 112(7): 2722 - 2729. [Abstract] [Full Text] [PDF]

				C. Langer, M. D. Radmacher, A. S. Ruppert, S. P. Whitman, P. Paschka, K. Mrozek, C. D. Baldus, T. Vukosavljevic, C.-G. Liu, M. E. Ross, et al. High BAALC expression associates with other molecular prognostic markers, poor outcome, and a distinct gene-expression signature in cytogenetically normal patients younger than 60 years with acute myeloid leukemia: a Cancer and Leukemia Group B (CALGB) study Blood, June 1, 2008; 111(11): 5371 - 5379. [Abstract] [Full Text] [PDF]

				J. K. Alder, R. W. Georgantas III, R. L. Hildreth, I. M. Kaplan, S. Morisot, X. Yu, M. McDevitt, and C. I. Civin Kruppel-Like Factor 4 Is Essential for Inflammatory Monocyte Differentiation In Vivo J. Immunol., April 15, 2008; 180(8): 5645 - 5652. [Abstract] [Full Text] [PDF]

				S. D. Nimer MDS: A Stem Cell Disorder--But What Exactly Is Wrong with the Primitive Hematopoietic Cells in This Disease? Hematology, January 1, 2008; 2008(1): 43 - 51. [Abstract] [Full Text] [PDF]

				L. Nilsson, P. Eden, E. Olsson, R. Mansson, I. Astrand-Grundstrom, B. Strombeck, K. Theilgaard-Monch, K. Anderson, R. Hast, E. Hellstrom-Lindberg, et al. The molecular signature of MDS stem cells supports a stem-cell origin of 5q myelodysplastic syndromes Blood, October 15, 2007; 110(8): 3005 - 3014. [Abstract] [Full Text] [PDF]

				R. W. Georgantas III, R. Hildreth, S. Morisot, J. Alder, C.-g. Liu, S. Heimfeld, G. A. Calin, C. M. Croce, and C. I. Civin CD34+ hematopoietic stem-progenitor cell microRNA expression and function: A circuit diagram of differentiation control PNAS, February 20, 2007; 104(8): 2750 - 2755. [Abstract] [Full Text] [PDF]

				M. A. Keller, S. Addya, R. Vadigepalli, B. Banini, K. Delgrosso, H. Huang, and S. Surrey Transcriptional regulatory network analysis of developing human erythroid progenitors reveals patterns of coregulation and potential transcriptional regulators Physiol Genomics, December 13, 2006; 28(1): 114 - 128. [Abstract] [Full Text] [PDF]

				J. Lotem, H. Benjamin, D. Netanely, E. Domany, and L. Sachs Induction in myeloid leukemic cells of genes that are expressed in different normal tissues PNAS, November 9, 2004; 101(45): 16022 - 16027. [Abstract] [Full Text] [PDF]